OTC Markets Group Inc (OTCQX:OTCM) said Tuesday that the Life Sciences Investor Forum has completed the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world.
This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. The program opens at 9.15 am ET on Thursday with the first live webcast at 9.30 am ET.
Investors can pre-register at: https://tinyurl.com/LSIF032620-AgendaPR. There is no cost to log-in, attend the live presentations or ask questions.
RedHill Biopharma Ltd (NASDAQ:RDHL) will kick off the virtual conference at 9.30 am, followed by Nuvo Pharmaceuticals Inc (OTCQX:NRIFF), Orexo AB (OTCQX:ORXOY), Emmaus Life Sciences Inc (OTCQB:EMMA), Moleculin Biotech Inc (Nasdaq:MBRX), Lexaria Bioscience Corp (OTCMKTS:LXRP) (CSE:LXX) and Beroni Group Ltd (OTCQX:BNIGF).
The Life Sciences Investor Forum on March 26, is part and parcel of the Virtual Investor Conferences (VIC) series, which comprises the OTC Market Group’s suite of investor access services.
Removing the time, resources and cost restraints associated with travel to traditional investor conferences, the VIC platform relies on the internet to gather people in one place, and acts as the glue that keeps companies and investor networks together.
Contact the author Uttara Choudhury at [email protected]einvestors.com
Follow her on Twitter: @UttaraProactive